Laboratory Testing for Perimenopause
Perimenopause should be diagnosed clinically based on menstrual history and age alone—laboratory testing is generally not recommended for women aged 45 and older with typical symptoms.
Primary Recommendation
The Endocrine Society guideline explicitly states that in women with an intact uterus, menopause is a clinical diagnosis based on cessation of menses, and sex steroids, gonadotropins, inhibin B, or anti-Müllerian hormone measurements do not further inform the diagnosis and will not influence management 1. This approach is strongly supported by research demonstrating that no single symptom or test is accurate enough to rule in or rule out perimenopause 2.
When Laboratory Testing May Be Considered
Laboratory testing should be reserved for specific clinical scenarios only:
Age-Based Indications
- Women aged 40-45 years with menopausal symptoms: FSH testing may be considered 3
- Women under age 40 with suspected premature ovarian insufficiency: FSH and estradiol testing indicated 3
Special Circumstances Requiring Labs
- Women who have undergone hysterectomy without bilateral oophorectomy: Use replicate measures of FSH and serum estradiol (estradiol <20 pg/mL supports menopause diagnosis) 1
- Women with inadequate menstrual history to ascertain menopausal status: Presumptive diagnosis based on vasomotor symptoms plus laboratory confirmation when indicated 1
Additional Testing to Consider (Not for Diagnosis)
While not needed to diagnose perimenopause, certain tests may guide treatment decisions:
- Thyroid function: To exclude thyroid hormone excess as a cause of vasomotor-like symptoms 1
- Lipid profile: If arterial disease history or high cardiovascular risk 3
- Thrombophilia screen: If high venous thromboembolism risk and considering hormone therapy 3
- Bone mineral density with turnover markers (β-CTX, PINP): For fracture risk assessment if considering hormone therapy 4
Common Pitfalls to Avoid
Do not order FSH testing routinely in women ≥45 years—this represents inappropriate testing that has been successfully reduced through educational interventions 5. FSH levels fluctuate significantly during perimenopause, making single measurements unreliable 4.
The clinical diagnosis relies on: Age (typically late 40s to early 50s) + menstrual pattern changes (cycle variation ≥7 days or 3-11 months amenorrhea) + symptoms (hot flashes, night sweats, vaginal dryness) 2. Self-assessment of going through the transition has reasonable accuracy (LR+ 1.53-2.13) 2.